(Berlin, March 26, 2010) The stock-listed medical device technology manufacturer W.O.M.
WORLD OF MEDICINE AG achieved a 3.3% return on sales before taxes for fiscal year 2009
(last year: 14.7%), despite a decline in sales of 14.0%.

"Against the backdrop of such a precarious and challenging market environment as well as
targeted investments in more development activities, this year's earnings development is
indeed satisfactory," says Peter P. Wiest, CEO of WORLD OF MEDICINE. "The reluctance to
invest was especially palpable in the US market. Asia showed the greatest level of stability."

Our cash and cash equivalents of €7.3 million and our equity ratio of 82.6% not only ensure
our financial independence, they also offer us sufficient leeway to invest in market
opportunities arising in the short-term. Our goal is to achieve sales growth in the low to
mid- single-digit range in 2010 and 2011, and to elevate the return on sales before taxes
compared to 2009. An economic recovery, particularly in the USA, is the precondition for
this.

The complete 2009 Annual Financial Report is available at the following link:
www.world-of-medicine.com/2009/annualfinancialreport/index.htm.

WORLD OF MEDICINE and its technologies are paving the way in Minimally Invasive Surgery - or MIS
for short. This approach includes safe and gentle surgical procedures conducted through keyhole or
puncture incisions, instead of major incisions. The Company is the global market leader in a niche of
this future market.

Further information: Stefanie Gehrke (PR), tel. +49 (0) 30 399 81 566, stefanie.gehrke@womcorp.com